Summary.-Optimized methods for extraction and enzyme assay in crude tissue preparations were used to determine the amounts of terminal deoxinucleotidyl transferase (TdT) in malignant lymphomas. The TdT concentration was increased only in lymphoblastic lymphomas (LL) and was as high in these tumours as in the white blood cells from untreated patients with acute lymphoblastic leukaemia (ALL). The enzymes extracted from such lymphomas and from the leukaemic lymphoblasts had the same properties. Moreover, forms of TdT with low and high mol. wt were found in the LL tumours, similar to other reports of TdT-positive leukaemias.
The overall study points at some basic biochemical identity of certain lymphoblastic malignancies, irrespective of whether the transformed cells are in solid tumours or are disseminated in the blood.
THE ENZYME TERMINAL deoxynucleotidyl transferase (TdT) catalyzes tle random condensation of deoxynucleotidyl residues on the 3'-OH termini of singlestranded DNA and of oligodeoxynucleotides (Bollum et al., 1964; Chang & Bollum, 1971 ; Kato et al., 1] 967; Yoneda & Bollum, 1965) . TdT has a restricted distribution in nature, and is abundant only in the thymus of higher animals (Bollum, 1978) , but it can be detected also in the marrow (Barr et al., 1976; Gregoire et al., 1977; Kung et et., 1975; Pazmino et al., 1977) and transiently in the spleen (Gregoire et al., 1979) . The enzyme is expressed in undifferentiated clones of migrating lynmphoid cells that will finally evolve to T lymphocytes in the thymus (Bollum, 1979; Gregoire et al., 1979; Silverstone et al., 1976) .
A general interest in TdT arose in 1973 after the reported presence of the enzyme in the neoplastic cells of acuite lymphatic leukaemia (ALL) (McCaffrey et al., 1973; Srivastava & Minowada, 1973) . Subsequently, TdT was found in the white blood cells from individuals with chronic myelogenous leukaemia (CML) during the blastic phase (Bhattacharyya, 1975; Sarin & Gallo, 1974; Srivastava et al., 1977) and in the blast cells from patients with acute undifferentiated leukaemia (AUL) (Kung et al., 1978; Marcus et al., 1976) . The data gained to date (Coleman et al., 1976 (Coleman et al., , 1978 Greenwood et al., 1977; Hutton et al., 1979; Kung et al., 1978; McCaffrey et al., 1975; Sarin et al., 1976) show that high levels of TdT are encountered in the immature cells from: most cases of ALL; 25-50% of CML in blast crisis; and a number of the so-called AUL. For these leukaemias, TdT is also a useful marker for the prediction of the response to therapy, since the cells with high TdT activity are often sensitive to cortisone (Kung et al., 1975; Sobhy & Chirpich, 1975 (Donlon et al., 1977; Habeshaw et al., 1979; Kung et al., 1978) . This paper complements the existing reports on the distribution of TdT in different lymphomas. It confirms that the enzyme is functionally expressed in the LL tissue and it shows that the intracellular concentration of TdT in these tumours can be as high as in the blasts in peripheral blood from ALL patients. We have also found either small or large mol.-wt forms of TdT in the LL tumours, similar to the enzymes of low (Coleman et al., 1974b; Marcus et al., 1976; Sarin et al., 1976) and high mol. wts (Deibel & Coleinan, 1979 ) that had been described in TdT+ leukaemias.
MATERIALS AND METHODS
Patients.-Neoplastic lymphoid tissues from 31 males and 18 females of ages ranging from 5-77, as well as non-neoplastic lymph nodes from 8 patients, were analysed. The lymphoma samples were from lymph nodes in 47 cases and from mediastinal masses in 2. They were obtained directly from the operating room after surgery, immediately frozen and stored at -70°C until use. For the sake of comparison, white mononucleated cells of peripheral blood from 3 patients with TdT+ leukaemias were also included in the study. Solid lymphoid tumours were classified histologically as proposed by Rappaport (1968) with the additional criteria introduced by Nathwani et al. (1976) for the definition of LL.
Chemicals and reagents.-Radioactive deoxynucleotides were purchased from Radiochemical Centre, Amersham. Unlabelled deoxynucleotides were from PL Biochemicals. Poly(dA)55 was prepared enzymatically in our laboratory via the end addition reaction catalysed by purified bovine TdT in the presence of an oligo(dA)6 initiator and dATP-Mg substrates (Kato et al., 1967 Assays of TdT.-The activity of human TdT was determined by measuring the induced polymerization of dGTP on an acidinsoluble (dA)n initiator as suggested by the group of Bollum for optimizing the enzyme assay in crude cell extracts (Chang, 1971; Chang & Bollum, 1971; Coleman et al., 1974a Coleman et al., , 1976 . Care was taken to choose reaction conditions ensuring maximal rates of catalysis. The composition of the standard assay was guided by the kinetic data obtained experimentally with an active lymphoma extract. and is presented under Results. The method finally adopted uses Mn++ instead of Mg++ as metal cofactor and is similar to that proposed by Coleman (1977a, b) for studying human leukaemias. One unit of TdT is the amount polymerizing 1 nmol of nucleotide material in 1 h. TdT activity is expressed in terms of units/0.1 g of tissue, a mass estimated as equivalent to 108 cells (Donlon et al., 1977) .
The TdT activity from calf thymus, purified according to the method of Yoneda & Bollum (1965) , was assayed for comparison with the human TdT in our standard incubation mixture. Parallel assays were run also with 8mM Mg++ as the divalent metal cofactor.
Ultracentrifugation analysis on sucrose gradients.-Sedimentation analysis of TdT activity in the tissue and cell extracts was carried out by centrifugation on sucrose gradients according to Martin & Ames (1961) . Linear gradients from 5-20%/ sucrose in 50mM Tris-HCI (pH 8.0), 500mM NaCl, 1mM EDTA were prepared in the cellulose nitrate tubes of the SW 50.1 rotor of a Beckman L8-70 ultracentrifuge, and were overlaid with 0-2 ml aliquots of crude extracts. The gradients were spun for 18 h at 40,000 rev/ min at 2°C. After centrifugation, serial fractions were collected from the bottom of the tubes and analysed for TdT activity. Bovine The rates of TdT reaction increased almost linearly on raising the concentration of dGTP substrate up to 0.2 mM, reached a maximum in the range of 0-2 to 1mM dGTP, and declined, because of inhibition, at higher levels (panel b).
The curves obtained for the saturation of TdT with Mg++ and Mn++ as metal cofactors are shown in panels c and d of Fig. 1 , respectively. In contrast to the bovine TdT, the human enzyme clearly preferred Mn++ to Mg++ for active catalysis with a (dA)n initiator as first noted by Bhattacharyya (1975 100 ,ul. The reaction was run at 37°C for up to 1 h, the time kinetics always being linear for 15 min and for up to 60 min in many instances. Aliquots (20 pl) of the assay mixture were drawn at various intervals of time, spotted on discs of glass-fibre paper (Whatman GF/C) and processed for the determination of radioactivity in the acid-insoluble material, as previously described (Bekkering-Kuylaars & Campagnari, 1972 ). Table I shows the various types of lymphoid tissues under study, and lists histological diagnosis, number of cases and the TdT concentrations. Most of the patients did not receive antiblastic therapy before the biopsy. The non-neoplastic lymph nodes taken as controls had a mean TdT content of 1-3 u/0-1 g of tissue, with values ranging from 0-5 to 2-7 times the mean.
Distribution of TdT activity in lymphontas
The only group of lymphomas displaying high TdT activity was that of the (Coleman, 1977a; Coleman et al., 1978) or leukaemic dissemination of LL (Hutton et al., 1979 LL is a useful clinical index for both the development of the tumour and its response to therapy as already noted by others in the leukaemias (Coleman et al., 1976; Marks et al., 1978) .
The TdT activities measured in the solid lymphoid tissues were in general 10 times larger than those found by previous investigators (Donlon et al., 1977; Habeshaw et al., 1979; Kung et al., 1978) . This refers to the LL tumours and to the other lymphomas with apparently normal enzyme content, but it applies also to nonneoplastic lymph nodes. The discrepancy must be related to methodological differences in the determination of the TdT activity in crude tissue extracts, and it will be commented upon under Discussion. Comparative study of the TdT activities from lymphomas and leukaemias relative to purified bovine TdT
The properties of the TdT extracted from LL tissue and from ALL cells were compared. The enzymes from the two sources yielded similar responses to the changes of the reactant concentrations in the assay. In fact, both TdT activities showed the same catalytic requirements and were saturated by the same distinctive concentrations of metal cofactors, dGTP and poly(dA)55. When dGTP was substituted by other deoxynucleoside triphosphates in the reaction mixture, the TdTs from both LL and ALL gave again the same response (Table II) . The reactions were carried out as described for the routine TdT assay with either the standard system of 0-5mM dGTP as a substrate and 0-5mM MnCl2 as a metal cofactor, or the indicated substitutions of 0 5mM dNTP nucleotide and 8mM MgCl2. The enzyme aliquots in the O lml assay mixtures were: 30 u of purified bovine TdT and the amounts of human TdT extracted from either 3-3 mg of tumour tissue or 4 x 105 mononuclear cells of leukaemic blood. Incubation was at 37°C for 10 min. The data are expressed as relative percentages of the polymerization value obtained with the standard dGTPMn combination.
However, the polymerization pattern obtained with the various nucleotides was different from that displayed by the purified TdT from calf thymus, which was tested in the presence of either Mn++ or Mg++. In this regard, the most striking difference was the much greater ability of the bovine enzyme to polymerize dUTP and dTTP substrates under our standard assay conditions (Table II) .
Sedimentation prqfiles of human TdT
The sedimentation analyses of the TdT recovered from cells of the two LLs and one ALL are presented in Fig. 2 gradients, and their estimated sedimentation coefficient of 3*45 and 3*70 S approached the 3*65 S measurement reported for the bovine thymus TdT (Chang & Bollum, 1971) . These data agree with the results by other investigators who found identical S values for the TdT enzymes from calf thymus and from the white blood cells from cases of acute myelomonocytic leukaemia (Coleman et al., 1974b) , of CML in blast crisis (Marcus et al., 1976) and of ALL .
On the other hand, the TdT activity of the extract from the Lm22 lymphoma (Fig. 2) sedimented faster than the Lm4 and Lk5 enzymes, and had a distinctly higher S value of 4-2. In this respect we should recall that TdT species with unexpectedly high mol. wt of about 60,000 have been noted in the neoplastic cells from two leukaemic patients (Diebel & Coleman, 1979) and from cultured human lymphoblastoid cells (Bollum & Brown, 1979) . As a matter of fact, our value of 4-2 S for the Lm22 would correspond to an apparent molecular size close to that estimated for the larger TdT enzymes.
DISCUSSION
The methods for the determination of TdT in extracts from human leukaemic cells have been extensively discussed by Coleman (1977a, b) . The recommended techniques involve the homogenization of the sample in buffers with relatively high salt concentrations and an enzymatic assay measuring the polymerization of dGTP on acid-insoluble (dA)n primers in the presence of Mn++.
We searched preliminarily for the best conditions to extract and to assay the TdT fronm normal and neoplastic lymph nodes. The standardized procedures permitted the detection of TdT levels that were all shifted to higher scale values than those found in solid lymphoid tumours with non-optimized assays by other investigators (Donlan et al., 1977; Habeshaw et al., 1979; Kung et al., 1978) .
Except for the quantitative scale difference of all the measurements, the TdT distribution we have noted in lymphoid tissues agrees with the previous investigations, showing abnormally high enzymatic activity in extracts from tumours that were classified as LL (Donlon et al., 1]977; Habeshaw et al., 1979; Kung et al., 1978) . As a matter of fact, the TdT enzymes from LL and from ALL showed similar intracellular increments over the average content of lymphoid tissues, and had the same catalytic properties.
The recent reports that human leukaemic cells can be endowed with TdT species with apparently the same molecular size as the enzyme isolated from calf thymus (Coleman et al., 1974b; Marcus et al., 1976; Sarin et al., 1976) or a higher mol. wt (Bollum & Brown, 1979; Deibel & Coleman, 1979) were matched by the results of our sedimentation analyses of the active extracts from LL tissues. Like the analogous leukaemias, these lymphoblastic tumours might consist of cell clones with functional expression of one or other form of TdT. Taken altogether the above observations seem to point to some basic biochemical similarity of the acute lymphoblastic malignancies, quite independent of the retention of the transformed cells in solid tumours or on their release into the blood.
TdT was first discovered in calf thymus and found to consist of a small protein with two distinct peptide chains (Chang & Bollum, 1971) . Initially regarded as an enzyme unique to thymus and of cytoplasmic origin (Bollum, 1978; Yoneda & Bollum, 1965) , the TdT has been subsequently detected in marrow (Barr et al., 1976; Gregoire et al., 1977; Kung et al., 1975; Pazmino et al., 1977) and also in other organs, during embryogenesis (Bollum, 1979; Gregoire et al., 1979) . Refined immunofluorescence methods showed that, in adult animals, TdT is localized to the nuclei of marrow cells and of large cortical thymocytes and to the cytoplasm of the small cortical thymocytes (Gregoire et al., 1979) . Apparently, the high-mol.-wt human TdT isolated from lymphoblastoid cells in culture (Bollum & Brown, 1979) and from leukaemic cells (Deibel & Coleman, 1977 ) is devoid of subunit structure and consists of a single polypeptide.
Bollum correlated the distinct molecular species of TdT with their intracellular location and function in thymus and nonthymic tissues (Bollum & Brown, 1979) . He suggested that the large TdT polypeptide in the nucleus of prothymocytes might be the functionally active enzyme which undergoes a post-translational cleavage of its peptide chain during differentiation in the thymus. The small TdT found in the cytoplasm of cortical thymocytes would result from the processing of the original gene product. This hypothesis muist await further experimental support, since the intracellular product of TdT has not been identified as yet, and the functions of the enzyme in the nucleus and in the cytoplasm of the lymphopoietic cells remain to be elucidated. Moreover, limited proteolysis is often a step in the maturation of proteins, and the peptide-chain cleavage of TdT in the thymus might not be a simple degradative operation. Anyway, the distinct forms of TdT in lymphoid neoplasias might reasonably be viewed as specific markers for populations of immature lymphocytes that underwent malignant transformation at different stages of maturation. 
